What is The TRUE BACK?
The TRUE BACK specializes in a non-powered orthopedic traction back stretcher device engineered to alleviate back pain, stress, and tension while simultaneously enhancing posture. Their innovative product is designed for portability and adjustability, aiming to deliver effective relief for a spectrum of back-related ailments. The company targets individuals grappling with chronic back pain, sciatica, and postural imbalances, offering a 90-day money-back guarantee to foster customer confidence. True Back emphasizes superior customer service and expedited shipping within the U.S., positioning itself as a reliable provider of at-home back pain solutions.
How much funding has The TRUE BACK raised?
The TRUE BACK has raised a total of $51K across 1 funding round:
Debt
$51K
Debt (2025): $51K, investors not publicly disclosed
What's next for The TRUE BACK?
With the recent influx of substantial expansion capital, The TRUE BACK is poised for significant growth and market penetration. This strategic financing at the Series B/C stage suggests a focus on scaling operations, potentially expanding product lines, and increasing marketing efforts to reach a broader audience suffering from back pain. The company's commitment to product efficacy and customer satisfaction, coupled with this financial backing, indicates a strong trajectory for future development and market leadership in the orthopedic device industry.
See full The TRUE BACK company page
